Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 4/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | PI4KA | P42356 | 1/20 | 0.31 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.31 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.31 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10153705 | 0.72 | FGFR1 (0.35) | FGFR1HTTSRCALDH1A1LMNA | |
| SCHEMBL10153685 | 0.70 | ALKBH5 (0.35) | — | |
| SCHEMBL10153633 | 0.61 | FGFR1 (0.51) | FGFR1HTTSRCALDH1A1LMNA | |
| SCHEMBL515911 | 0.60 | ADORA2B (0.61) | HTTALDH1A1LMNA | |
| SCHEMBL10153438 | 0.60 | FGFR1 (0.35) | FGFR1HTTSRC | |
| SCHEMBL15906393 | 0.60 | FGFR1 (0.46) | FGFR1HTTSRCEGFRPI4KA | |
| SCHEMBL27582932 | 0.58 | MAPK1 (0.56) | HTTALDH1A1 | |
| SCHEMBL2252071 | 0.56 | FGFR1 (0.54) | FGFR1HTTSRC | |
| SCHEMBL29109468 | 0.56 | PDE4A (0.49) | FGFR1HTTSRCEGFRPI4KA | |
| SCHEMBL8013328 | 0.56 | FGFR1 (0.54) | FGFR1HTTSRCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-8421066-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2013-04-16 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-07-12 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8174002-B2 | Organic electroluminescence device | FUJIFILM CORPORATION (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100051928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | FGFR1 955/4885HTT 2212/4885SRC 3323/4885 |
| US-20120178928-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | L1CAM, CHRM1, LEF1 | FGFR1 955/4885HTT 2212/4885SRC 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.